{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:39:13Z","timestamp":1791160753685,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology in Vitro"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.tiv.2013.09.013","type":"journal-article","created":{"date-parts":[[2013,9,19]],"date-time":"2013-09-19T17:37:43Z","timestamp":1379612263000},"page":"187-197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Transferrin as a drug carrier: Cytotoxicity, cellular uptake and transport kinetics of doxorubicin transferrin conjugate in the human leukemia cells"],"prefix":"10.1016","volume":"28","author":[{"given":"Marzena","family":"Szwed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Matusiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Laroche-Clary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Robert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilona","family":"Marszalek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zofia","family":"Jozwiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tiv.2013.09.013_b0010","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1751-1097.1996.tb02436.x","article-title":"Kinetic transport analysis of daunorubicin by LoVo and LoVo\/DX cells","volume":"64","author":"Andreoni","year":"1996","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.tiv.2013.09.013_b0015","doi-asserted-by":"crossref","first-page":"9437","DOI":"10.1016\/S0021-9258(19)50442-2","article-title":"Transferrin conjugates of adriamycin are cytotoxic without intercalating nuclear DNA","volume":"5","author":"Barabas","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tiv.2013.09.013_b0020","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1432-1033.1993.tb17778.x","article-title":"Influence of conjugation of doxorubicin to transferrin on the iron uptake by K562 cells via receptor-mediated endocytosis","volume":"213","author":"Berczi","year":"1993","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.tiv.2013.09.013_b0025","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1021\/jm9704661","article-title":"Synthesis and in vitro efficacy of transferrin conjugates of the anticancer drug chlorambucil","volume":"41","author":"Beyer","year":"1998","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tiv.2013.09.013_b0030","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s11064-007-9469-8","article-title":"Delineating the mechanism of Alzheimer\u2019s disease A\u03b2 peptide neurotoxicity","volume":"33","author":"Cappai","year":"2008","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.tiv.2013.09.013_b0035","doi-asserted-by":"crossref","first-page":"6156","DOI":"10.1021\/nn200693a","article-title":"Aptamer-conjugated DNA icosahedral nanoparticles as a carrier of doxorubicin for cancer therapy","volume":"23","author":"Chang","year":"2011","journal-title":"ACS Nano"},{"key":"10.1016\/j.tiv.2013.09.013_b0040","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1007\/s11095-006-9043-0","article-title":"The role of the VPS4A-exosome pathway in the intrinsic egress route of a DNA-binding anticancer drug","volume":"23","author":"Chen","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.tiv.2013.09.013_b0045","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-1-61779-188-8_9","article-title":"Aptamer-drug conjugation for targeted tumor cell therapy","volume":"764","author":"Donovan","year":"2011","journal-title":"Method Mol. Biol."},{"key":"10.1016\/j.tiv.2013.09.013_b0050","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/128_2007_12","article-title":"Doxorubicin conjugates for selective delivery to tumors","volume":"283","author":"Florent","year":"2008","journal-title":"Top. Curr. Chem."},{"key":"10.1016\/j.tiv.2013.09.013_b0055","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0006-2952(98)00307-4","article-title":"A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin","volume":"7","author":"Gewirtz","year":"1999","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tiv.2013.09.013_b0060","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1002\/rcm.1641","article-title":"Applications of a travelling wave-based radio-frequency-only stacked ring ion guide","volume":"18","author":"Giles","year":"2004","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.tiv.2013.09.013_b0065","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1002\/anie.200502113","article-title":"Polymer therapeutics: concepts and applications","volume":"45","author":"Haag","year":"2006","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.tiv.2013.09.013_b0070","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1158\/1535-7163.MCT-06-0580","article-title":"Expression of human glutathione S-transferase P1 mediates the chemosensitivity of osteosarcoma cells","volume":"6","author":"Huang","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.tiv.2013.09.013_b0075","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1177\/153303460800700611","article-title":"Recent advances in protection against doxorubicin-induced toxicity","volume":"7","author":"Injac","year":"2008","journal-title":"Technol. Cancer Res. Treat."},{"key":"10.1016\/j.tiv.2013.09.013_b0080","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/jjco\/hyl004","article-title":"Doxorubicin-conjugated anti-midkine monoclonal antibody as a potential anti-tumor drug","volume":"36","author":"Inoh","year":"2006","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.tiv.2013.09.013_b0085","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/ijc.10242","article-title":"Intracellular targeting therapy of cisplatin-encapsulated transferrin-polyethyleneglycol liposome on peritoneal dissemination of gastric cancer","volume":"99","author":"Inuma","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.tiv.2013.09.013_b0090","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/FPC.0b013e328350e270","article-title":"The G671V variant of MRP1\/ABCC1 links doxorubicin-induced acute cardiac toxicity to disposition of the glutathione conjugate of 4-hydroxy-2-trans-nonenal","volume":"22","author":"Jungsuwadee","year":"2012","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.tiv.2013.09.013_b0095","article-title":"A unique carrier for delivery of therapeutic compounds beyond the blood-brain barrier","volume":"25","author":"Karkan","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tiv.2013.09.013_b0100","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jmb.2011.01.012","article-title":"Ion mobility separation coupled with MS detects two structural states of Alzheimer\u2019s disease A\u03b21-40 peptide oligomers","volume":"4071","author":"Kloniecki","year":"2011","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.tiv.2013.09.013_b0105","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.brainres.2004.10.041","article-title":"Soluble A\u03b2 oligomers ultrastructurally localize to cell processes and might be related to synaptic dysfunction in Alzheimer\u2019s disease brain","volume":"1031","author":"Kokubo","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.tiv.2013.09.013_b0110","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1021\/bc060246e","article-title":"The same drug but a different mechanism of action: comparison of free doxorubicin with two different N-(2 hydroxypropyl)methacrylamide copolymer-bound doxorubicin conjugates in EL-4 cancer cell line","volume":"1","author":"Kov\u00e1r","year":"2007","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.tiv.2013.09.013_b0115","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/cmdc.200700159","article-title":"Prodrug strategies in anticancer chemotherapy","volume":"3","author":"Kratz","year":"2008","journal-title":"Chem. Med. Chem."},{"key":"10.1016\/j.tiv.2013.09.013_b0120","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1440-1681.2009.05252.x","article-title":"Multidrug resistance-associated proteins and implications in drug development","volume":"37","author":"Liu","year":"2010","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.tiv.2013.09.013_b0125","first-page":"72","article-title":"Transferrin conjugates in the anticancer therapy","volume":"52","author":"Lubgan","year":"2006","journal-title":"Postepy Biochem."},{"key":"10.1016\/j.tiv.2013.09.013_b0130","first-page":"113","article-title":"Doxorubicin\u2013transferrin conjugate selectively overcomes multidrug resistance in leukaemia cells","volume":"1","author":"Lubgan","year":"2009","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.tiv.2013.09.013_b0135","doi-asserted-by":"crossref","first-page":"7796","DOI":"10.1021\/nn201592s","article-title":"Release of photoactivatable drugs from plasmonic nanoparticles for targeted cancer therapy","volume":"25","author":"Luo","year":"2011","journal-title":"ACS Nano"},{"key":"10.1016\/j.tiv.2013.09.013_b0140","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ejpb.2008.11.010","article-title":"Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect","volume":"71","author":"Maeda","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.tiv.2013.09.013_b0145","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.bbagen.2011.09.009","article-title":"The intracellular trafficking pathway of transferring","volume":"1820","author":"Mayle","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tiv.2013.09.013_b0150","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jconrel.2007.08.029","article-title":"Yang, in vitro assessment of a novel polyrotaxane-based drug delivery system integrated with a cell-penetrating peptide","volume":"4","author":"Moon","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.tiv.2013.09.013_b0155","doi-asserted-by":"crossref","first-page":"5137","DOI":"10.1021\/ac030107f","article-title":"Development of high-sensitivity ion trap ion mobility spectrometry time-of-flight techniques: a high-through put nano-LC-IMS-TOF separation of peptides arising from a Drosophila protein extract","volume":"75","author":"Myung","year":"2003","journal-title":"Anal. Chem."},{"key":"10.1016\/j.tiv.2013.09.013_b0160","first-page":"350","article-title":"Current status of research on conjugates and related drug delivery systems in the treatment of cancer and other diseases","volume":"61","author":"Nevozhay","year":"2007","journal-title":"Postepy. Hig. Med. Dosw."},{"key":"10.1016\/j.tiv.2013.09.013_b0165","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1006\/cbir.2000.0583","article-title":"Cytotoxicity of daunorubicin in trisomic (+21) human fibroblasts: relation to drug uptake and cell membrane fluidity","volume":"25","author":"Przybylska","year":"2001","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.tiv.2013.09.013_b0170","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jpba.2004.06.012","article-title":"Quantification intracellular levels of oligodeoxynucleotide\u2013doxorubicin conjugate in human carcinoma cells in situ","volume":"29","author":"Ren","year":"2004","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.tiv.2013.09.013_b0175","doi-asserted-by":"crossref","first-page":"8001","DOI":"10.1002\/anie.200702161","article-title":"Ion mobility mass spectrometry reveals long-lived, unfolded intermediates in the dissociation of protein complexes","volume":"46","author":"Ruotolo","year":"2007","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.tiv.2013.09.013_b0180","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/nprot.2008.78","article-title":"Ion mobility mass spectrometry analysis of large protein complexes","volume":"3","author":"Ruotolo","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.tiv.2013.09.013_b0185","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1124\/jpet.111.190256","article-title":"Pharmacokinetic characterization of amrubicin cardiac safety in an ex vivo human myocardial strip model I. Amrubicin accumulates to a lower level than doxorubicin or epirubicin","volume":"15","author":"Salvatorelli","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tiv.2013.09.013_b0190","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/10611860600833955","article-title":"Establishment of subcellular fractionation techniques to monitor the intracellular fate of polymer therapeutics I. Differential centrifugation fractionation B16F10 cells and use to study the intracellular fate of HPMA copolymer \u2013 doxorubicin","volume":"14","author":"Seib","year":"2006","journal-title":"J. Drug Target."},{"key":"10.1016\/j.tiv.2013.09.013_b0195","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1021\/jp2091363","article-title":"Intermolecular Interactions between doxorubicin and \u03b2-cyclodextrin 4-methoxyphenol conjugates","volume":"16","author":"Swiech","year":"2012","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.tiv.2013.09.013_b0200","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1248\/bpb.24.268","article-title":"Receptor mediated endocytosis and cytotoxicity of transferrin\u2013mitomycin C conjugate in the HepG2 cell and primary cultured rat hepatocyte","volume":"24","author":"Tanaka","year":"2001","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.tiv.2013.09.013_b0205","first-page":"682","article-title":"Characteristics of resistance to adriamycin in human myelogenous leukemia K562 resistant to adriamycin and in isolated clones","volume":"7","author":"Tsuruo","year":"1986","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1016\/j.tiv.2013.09.013_b0210","first-page":"350","article-title":"Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil","volume":"10","author":"Wu","year":"2007","journal-title":"J. Pharm. Pharm. Sci."}],"container-title":["Toxicology in Vitro"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233313002221?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233313002221?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,6]],"date-time":"2022-03-06T13:26:18Z","timestamp":1646573178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887233313002221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0887233313002221"],"URL":"https:\/\/doi.org\/10.1016\/j.tiv.2013.09.013","relation":{},"ISSN":["0887-2333"],"issn-type":[{"value":"0887-2333","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transferrin as a drug carrier: Cytotoxicity, cellular uptake and transport kinetics of doxorubicin transferrin conjugate in the human leukemia cells","name":"articletitle","label":"Article Title"},{"value":"Toxicology in Vitro","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tiv.2013.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}